We have demonstrated Th2 clonal anergy as a consequence of partial T cell activation by immunogenic peptide and chemically fixed APC, as well as by altered peptide ligand and live antigen-presenting cells (APC). Either stimulation resulted in a profound inability of the T cells to proliferate upon restimulation with antigen and functional APC, a similar phenomenon to that found with Th1 cells. The anergic state was long lasting and was restricted to proliferation, since the T cells retained the ability to produce cytokines upon restimulation, albeit at slightly reduced levels. Th2 anergy induction was inhibited by cyclosporine A, but not by provision of exogenous costimulation or growth factors. The data presented unify Th1 and Th2 cells with regard to anergy and suggest that the fundamental control during anergy for both subsets is prevention of clonal expansion, thus blocking amplification of the immune response.
Skip Nav Destination
Article navigation
1 October 1994
Article|
October 01 1994
Th2 cell clonal anergy as a consequence of partial activation.
J Sloan-Lancaster,
J Sloan-Lancaster
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Search for other works by this author on:
B D Evavold,
B D Evavold
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Search for other works by this author on:
P M Allen
P M Allen
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Search for other works by this author on:
J Sloan-Lancaster
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
B D Evavold
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
P M Allen
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 180 (4): 1195–1205.
Citation
J Sloan-Lancaster, B D Evavold, P M Allen; Th2 cell clonal anergy as a consequence of partial activation.. J Exp Med 1 October 1994; 180 (4): 1195–1205. doi: https://doi.org/10.1084/jem.180.4.1195
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement